Definium Therapeutics Announces New Employee Inducement Grants
Definium Therapeutics granted inducement options to eight newly hired non-executive employees, covering an aggregate of 169,740 common shares. The options vest over a four-year period, with 25% vesting on the first anniversary and the remainder vesting in monthly installments thereafter.
Key figures
- Grantee count
- 8
- Options granted
- 169740
- Vesting term years
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.